Beijing Tong Ren Tang Chinese Medicine Co (HKSE:03613) Net Income From Continuing Operations : HK$591 Mil (TTM As of Dec. 2023)

View and export this data going back to 2013. Start your Free Trial

What is Beijing Tong Ren Tang Chinese Medicine Co Net Income From Continuing Operations?

Net Income From Continuing Operations indicates the net income that a firm brings in from ongoing business activities. These activities are expected to continue into the next reporting period. Beijing Tong Ren Tang Chinese Medicine Co's net income from continuing operations for the six months ended in Dec. 2023 was HK$293 Mil. Its net income from continuing operations for the trailing twelve months (TTM) ended in Dec. 2023 was HK$591 Mil.

Beijing Tong Ren Tang Chinese Medicine Co Net Income From Continuing Operations Historical Data

The historical data trend for Beijing Tong Ren Tang Chinese Medicine Co's Net Income From Continuing Operations can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Beijing Tong Ren Tang Chinese Medicine Co Net Income From Continuing Operations Chart

Beijing Tong Ren Tang Chinese Medicine Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Net Income From Continuing Operations

Get a 7-Day Free Trial

689.22

685.90

778.39

825.96

687.79

Beijing Tong Ren Tang Chinese Medicine Co Semi-Annual Data
	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Net Income From Continuing Operations	Get a 7-Day Free Trial															360.83	238.12	453.17	297.87	292.72

Beijing Tong Ren Tang Chinese Medicine Co Net Income From Continuing Operations Calculation

Net Income From Continuing Operations indicates the net income that a firm brings in from ongoing business activities. These activities are expected to continue into the next reporting period. It excludes extraordinary items, income from the cumulative effects of accounting changes, non-recurring items, income from tax loss carry forward, and preferred dividends.

Net Income From Continuing Operations for the trailing twelve months (TTM) ended in Dec. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was HK$591 Mil.

Beijing Tong Ren Tang Chinese Medicine Co (HKSE:03613) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Beijing Tong Ren Tang Chinese Medicine Co Ltd (HKSE:03613) » Definitions » Net Income From Continuing Operations

Traded in Other Exchanges

TQR:Germany

Address

Convention Plaza, 1 Harbour Road, Room 1405-1409, Office Tower, Wanchai, Hong Kong, HKG

Website

https://cm.tongrentang.com

Beijing Tong Ren Tang Chinese Medicine Co Ltd is a pharmaceutical retailer that specializes in Chinese medicine operating in three segments; Hong Kong includes the sale of Chinese medicine products and healthcare products and the provision of Chinese medical consultation and treatments through retail and wholesale of Chinese medicine products and healthcare products, Mainland China (PRC, but excluding Hong Kong, Macao, and Taiwan) includes wholesale of healthcare products in Mainland China and the sole distributor of Tong Ren Tang branded products of Tong Ren Tang Technologies and Tong Ren Tang Ltd, and Overseas includes retail and wholesale of Chinese medicine products and healthcare products and provision of Chinese medical consultation and treatments.

Beijing Tong Ren Tang Chinese Medicine Co (HKSE:03613) Headlines

No Headlines